GENE ONLINE|News &
Opinion
Blog

AAV Vectors
Harnessing Viral Evolution to Deliver Gene Therapy to Specific Tissues
2021-09-13
Biogen Inks $120 Million Pact with High Flying Ginkgo Bioworks to Redefine Manufacturing of Gene Therapy Vectors
2021-05-23
The Transformative Potential of Gene Therapies for Hemophilia
2021-04-08
Overview of the Gene Therapy Revolution: Hopeful Beginnings, Tribulations, and Resurgence
2021-03-23
Jaguar Launches with a Pre-clinical Pipeline of AAV9-Based Gene Therapies
2021-02-28
Sanofi Joins Hands with German Biotech to Develop Improved AAV Capsids for Gene Therapies
2021-02-28
Ensoma Enters Gene-Editing Market with $70 Million Funding and Takeda Partnership
2021-02-12
Is Bayer’s Entry to the Gene Therapy Market Worth it’s Investment?
2020-10-27
Pfizer, Sangamo Dose First Hemophilia A Patient in Phase 3 with Gene Therapy Candidate
2020-10-08
Novartis Enters $75 Million Collaboration with Sangamo for its Zinc Finger Gene Editing Technology
2020-08-01
Daiichi Sankyo Invests in Ultragenyx’s Technology to Bolster Gene Therapy Pipeline
2020-04-02
LATEST
BIO 2023 Coming to Boston, with Over 60 Taiwanese Organizations to Share their Achievements
2023-06-02
2023 ASGCT Annual Meeting: Showcase of Exciting New Research, with a Focus on Clinical Applications
2023-06-02
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
Scroll to Top